7 - 7 |
Moving on reputation Hunter D |
11 - 11 |
ACC commits to security code; Responsible care overhaul Westervelt R |
11 - 11 |
DQJ bars public access to terror vulnerability report Franz N |
12 - 12 |
Methanex plans bond offering; May pay a dividend Westervelt R |
12 - 12 |
Millennium passes on oxy's equistar stake Westervelt R |
12 - 12 |
Farmland files for chapter 11 bankruptcy protection Sim PH |
13 - 13 |
States sue Bristol-Myers over cancer drug patents Mullin R |
13 - 13 |
FMC to cut debt via share offering Walsh K |
13 - 13 |
Pequiven workers plan strike over contract dispute Sissell K |
13 - 13 |
US may impose duties on east European fertilizers Sim PH |
14 - 14 |
Texas relaxes NOx mandate Sissell K |
14 - 14 |
Noveon buys personal care distributor in Mexico Walsh K |
15 - 15 |
Acetex to acquire rhodia's PVA and acetic acid derivatives Young I |
15 - 15 |
Sabic reorganizes following DSM petchems purchase [Anonymous] |
15 - 15 |
UK launches national debate on GM crops Scott A |
16 - 16 |
DMF players mull plants in China Moore S |
18 - 19 |
Downturn compounds processors' problems Westervelt R |
20 - 20 |
Advanced polyolefins take hold in the market Sim PH |
24 - 24 |
Enterprise applications set for rapid growth Mullin R |
24 - 24 |
Rohm and Haas connects the dots Mullin R |
25 - 25 |
Mitsubishi chemical develops catalytic EG process Moore S |
25 - 25 |
Robots'knit' tailored carbon composites Scott A |
26 - 27 |
Boehringer Ingelheim builds on its biologics lead Hunter D |
28 - 28 |
Akzo Nobel starts up powder-based expansion Schmitt B |
28 - 28 |
Recession dims growth; Some markets shine Schmitt B |
29 - 29 |
Suppliers cater to formulators and niche tastes Schmitt B |
31 - 31 |
European PVC increase should stick Cage S |
31 - 31 |
Inventory pile-up may stall prices Sim PH |
32 - 32 |
Product focus [Anonymous] |
33 - 33 |
Product focus - Commentary [Anonymous] |
34 - 34 |
EPA releases toxics risk assessment Franz N |
34 - 34 |
Groups sue EPA over air standards Sissell K |
34 - 34 |
NRDC seeks atrazine ban Sissell K |
39 - 39 |
Vital statistics Pearlman A |